NCT02737228 - Study of CG200745 PPA in Combination With Gemcitabine and Erlotinib for Advanced Pancreatic Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

August 31, 2019

Study Completion Date

August 31, 2019

Conditions

Pancreatic Neoplasms

Interventions

DRUG

CG200745 PPA

CG200745 PPA IV every week three times per cycle (4 weeks)

DRUG

Gemcitabine

1000 mg/m\^2 intravenously every week three times per cycle (4 weeks)

DRUG

Erlotinib

100 mg per oral daily per cycle (4 weeks)

Trial Locations (1)

Yonsei University Health System, Seoul